Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2019

Sep 3, 2019

32641_dirs_2019-09-03_234b62ed-422a-488f-8a44-3649d4827358.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MRI INTERVENTIONS, INC. (MRIC)
CIK: 0001285550
Period of Report: 2019-09-01

Reporting Person: JOHNSON B KRISTINE (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-01 Stock Option (right to buy) $3.92 A 15000 Acquired 2029-09-01 Common Stock (15000) Direct

Footnotes

F1: The shares subject to this option vest ratably on the first, second and third anniversaries of the grant date, September 1, 2020, September 1, 2021 and September 1, 2022.